Phase 2 Study Evaluating the Combination of Sorafenib and Temsirolimus in the Treatment of Radioactive Iodine-Refractory Thyroid Cancer
Cancer - United States
doi 10.1002/cncr.30861
Full Text
Open PDFAbstract
Available in full text
Date
June 29, 2017
Authors
Publisher
Wiley